ArticleScientific reports2023
Effect of Mo doping in NiO nanoparticles for structural modification and its efficiency for antioxidant, antibacterial applications.
Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Bioengineered zinc oxide nanoparticles derived from Teucrium polium as a multifunctional platform for anticancer activity, hemocompatibility, larval toxicity and photocatalytic remediation.Scientific reports · 2026Article
- Synthesis of chitosan/PVA/copper oxide nanocomposite using Anacardium occidentale extract and evaluating its antioxidant, antibacterial, anti-inflammatory and cytotoxic activities.Scientific reports · 2025Article
- Article
- Gelatin/PLA-loaded gold nanocomposites synthesis using Syzygium cumini fruit extract and their antioxidant, antibacterial, anti-inflammatory, antidiabetic and anti-Alzheimer's activities.Scientific reports · 2025Article
- Antibacterial Activity of Molybdenum Oxide-Polyacrylonitrile Composite Membrane with Fast Silver Ion Reduction.ACS omega · 2023Article
- Long-Term Stable Complementary Electrochromic Device Based on WOMembranes · 2023Article
- Effect of the molar ratio of (NiScientific reports · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Novel molybdenum (Mo)-doped nickel oxide (NiO) Nanoparticles (NPs) were synthesized by using a simple sonochemical methodology and the synthesized NPs were investigated for antioxidant, and antibacterial applications. The X-ray diffraction (XRD) analysis revealed that the crystal systems of rhombohedral (21.34 nm) and monoclinic (17.76 nm) were observed for pure NiO and Mo-doped NiO NPs respectively. The scanning electron microscopy (SEM) results show that the pure NiO NPs possess irregular spherical shape with an average particle size of 93.89 nm while the Mo-doped NiO NPs exhibit spherical morphology with an average particle size of 85.48 nm. The ultraviolet-visible (UV-Vis) spectrum further indicated that the pure and Mo-doped NiO NPs exhibited strong absorption band at the wavelengths of 365 and 349 nm, respectively. The free radical scavenging activity of NiO and Mo-doped NiO NPs was also investigated by utilizing several biochemical assays. The Mo-doped NiO NPs showed better antioxidant activity (84.2%) towards ABTS. + at 200 µg/mL in comparison to their pure counterpart which confirmed that not only antioxidant potency of the doped NPs was better than pure NPs but this efficacy was also concentration dependant as well. The NiO and Mo-doped NiO NPs were further evaluated for their antibacterial activity against gram-positive (Staphylococcus aureus and Bacillus subtilis) and gram-negative (Pseudomonas aeruginosa and Escherichia coli) bacterial strains. The Mo-doped NiO NPs displayed better antibacterial activity (25 mm) against E. coli in comparison to the pure NPs. The synthesized NPs exhibited excellent aptitude for multi-dimensional applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.